Trial Profile
Phase III programme of four studies with tedatioxetine in patients with moderate-to-severe major depressive disorder
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 22 Mar 2010
Price :
$35
*
At a glance
- Drugs Tedatioxetine (Primary)
- Indications Major depressive disorder
- Focus Registrational; Therapeutic Use
- Sponsors Lundbeck A/S; Takeda
- 22 Mar 2010 New trial record